Skip to main content

Alteogen

Alteogen Inc. is a South Korean biotechnology company focused on developing long-acting biobetters, biosimilars, and antibody-drug conjugates. The company leverages proprietary technology platforms, notably Hybrozyme, which enables the subcutaneous administration of intravenously delivered biopharmaceuticals. Its core product pipeline centers on human hyaluronidase enzymes alongside biosimilar formulations targeting oncology and ophthalmic conditions. Primary revenue drivers are upfront technology licensing fees, development milestone payments, and ongoing royalty streams from global pharmaceutical licensees. Alteogen holds a prominent market position as a leading innovator in drug delivery formulation technologies. The company is headquartered in Daejeon, South Korea, and its shares trade on the KOSDAQ market.

16 of the funds FundTelligence covers report a position in Alteogen.

Legal name
Alteogen Inc
Sector
Health Care
Country
South Korea
Funds holding it
16

Funds holding Alteogen

Showing the 8 largest of 16 funds holding it.

Loading...